NovaBay Pharmaceuticals, Inc. (NBY)

NovaBay Pharmaceuticals Market Cap

NovaBay Pharmaceuticals has a market cap or net worth of $75.3 million as of February 12, 2026. Its market cap has increased by 2,181.90% in one year.

• Market Cap: 75.30M
• Enterprise Value: 78.77M
• 1-Year Change: 2,181.90%
• Ranking: #4289
• Category: Micro-Cap
• Stock Price: $0.58

Market Cap Chart

Since October 26, 2007, NovaBay Pharmaceuticals's market cap has decreased from $76.50M to $75.30M, a decrease of -1.57%. That is a compound annual growth rate of -0.09%.

Market Cap History

Date	Market Cap	% Change
Feb 11, 2026	83.40M	-88.27%
Dec 31, 2025	710.70M	24,406.90%
Dec 31, 2024	2.90M	123.08%
Dec 29, 2023	1.30M	-63.89%
Dec 30, 2022	3.60M	-78.70%
Dec 31, 2021	16.90M	-41.92%
Dec 31, 2020	29.10M	62.57%
Dec 31, 2019	17.90M	35.61%
Dec 31, 2018	13.20M	-77.70%
Dec 29, 2017	59.20M	18.64%
Dec 30, 2016	49.90M	612.86%
Dec 31, 2015	7.00M	-78.46%
Dec 31, 2014	32.50M	-32.85%
Dec 31, 2013	48.40M	43.62%
Dec 31, 2012	33.70M	-11.32%
Dec 30, 2011	38.00M	-1.81%
Dec 31, 2010	38.70M	-19.21%
Dec 31, 2009	47.90M	118.72%
Dec 31, 2008	21.90M	-72.59%
Dec 31, 2007	79.90M	4.44%
Oct 26, 2007	76.50M	-

View and export this data all the way back to 2007. Sign Up Today.

Related Stocks

Company	Market Cap
Artiva Biotherapeutics	95.48M
Biomea Fusion	95.45M
Equillium	92.56M
Oncolytics Biotech	90.63M
Precision BioSciences	90.51M
Spruce Biosciences	89.51M
eXoZymes	87.11M
Pyxis Oncology	86.55M